For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029. This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Cancer Diagnostics as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Types Segment:
- Liquid biopsy microdevices
- Microfluidic immunohistochemistry
- Paper microfluidic devices
Companies Covered:
- Abbott Laboratories Inc.
- Cepheid Inc.
- Philips
- GE Healthcare
- Siemens
- Gen-Probe Incorporated
- MDxHealth SA
- EpiGenomics AG
- Roche Diagnostics
- Exact Sciences Corporation
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Abbott Laboratories Inc.
- Cepheid Inc.
- Philips
- GE Healthcare
- Siemens
- Gen-Probe Incorporated
- MDxHealth SA
- EpiGenomics AG
- Roche Diagnostics
- Exact Sciences Corporation
- Sequenom Inc.
- Cannabics Pharmaceuticals Inc.